Latest in Pulmonary News

Thirty-Day Hospital Readmission Metric Linked to Increased Mortality for HF and Pneumonia

Physicians are at increased pressure to reduce readmissions for certain chronic diseases. A recent study found that implementation of the 30-day readmission rules has been associated with increased 30-day post-discharge mortality for those hospitalized for heart failure and pneumonia.

Post-discharge deaths have increased by 0.25% for patients hospitalized with heart failure and by 0.40% for patients with pneumonia since the implementation of the 30-day readmission rules.
There are approximately 8 million hospitalizations during the study period. Such small increases may account for a large number of deaths.

The findings, published online in JAMA, come from a retrospective cohort study that compared mortality rates among 8.3 million Medicare beneficiaries hospitalized for these common conditions before and after implementation of the Hospital Readmissions Reduction Program (HRRP). This early data should lead physicians to exercise caution in discharging patients prematurely.

Source: Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia. JAMA. 2018;320(24):2542-2552. doi:10.1001/jama.2018.19232

Add Corticosteroids to Your Arsenal for the treatment of Inpatient Community-Acquired Pneumonia.

Corticosteroids were both beneficial and cost-effective for hospitalized adults with severe CAP. Hospitalized people with non-severe CAP may also benefit from corticosteroid therapy, but with no survival advantage

In 2015, results of two randomized trials showed that systemic corticosteroids were beneficial for some hospitalized patients with community-acquired pneumonia (CAP; NEJM JW Gen Med Mar 15 2015 and JAMA 2015; 313:677; NEJM JW Gen Med Mar 1 2015 and Lancet 2015; 385:1511). Now, two new meta-analyses — one by the Cochrane Library, and one by the Infectious Diseases Society of America (IDSA) — address whether CAP patients should receive systemic corticosteroids routinely.

These meta-analyses suggest that low-dose (≈40 mg), short-course (3–7 days) systemic corticosteroids should be strongly considered for hospitalized adults with severe CAP. These results do not apply to outpatients with CAP or to inpatients with hospital-acquired pneumonia or ventilator-associated pneumonia. Several ongoing randomized trials probably will clarify steroid use further for pneumonia indications.

Source:
The Cost-effectiveness of Corticosteroids for the treatment of Community-Acquired Pneumonia
Chest. 2018 Nov 15. pii: S0012-3692(18)32727-2. doi: 10.1016/j.chest.2018.11.001.
https://www.ncbi.nlm.nih.gov/pubmed/30448195?dopt=Abstract

Home oxygen therapy for COPD: Does it matter whether the patient is hypoxemic? Evidence vs Reality

Home oxygen therapy for COPD: Does it matter whether the patient is hypoxemic? Evidence vs Reality?

Long-term oxygen therapy (LTOT) is given to improve survival time in people with COPD and severe chronic hypoxemia at rest. The efficacy of oxygen therapy for breathlessness and health-related quality of life (HRQOL) in people with COPD and mild or no hypoxemia who do not meet the criteria for LTOT has not been established. Scientific evidence for its benefits of LTOT dates back to the 1980s when two randomized controlled trials showed prolonged survival in COPD-patients undergoing LTOT for at least 15 hours/day. In contrast, the potential benefits of LTOT in non-COPD-patients has not been well researched and the recommendations for its application are primarily extrapolated from trials on COPD-patients.

Recent Cochrane analysis found that oxygen can relieve breathlessness when given during exercise to mildly hypoxaemic and non-hypoxaemic people with chronic obstructive pulmonary disease who would not otherwise qualify for home oxygen therapy. Findings show that COPD patients without severe hypoxemia undergoing oxygen therapy during exercise training over time do not achieve better exercise capacity or health-related quality of life compared with placebo.

However, LTOT has a beneficial effect on quality of life, dyspnea, and exercise capacity in patients with COPD and exertional hypoxemia.

Source:
Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006429.pub3/full

J Bras Pneumol. 2018 Sep-Oct;44(5):390-397. doi: 10.1590/S1806-37562017000000019.
Impact of adherence to long-term oxygen therapy on patients with COPD and exertional hypoxemia followed for one year.
https://www.ncbi.nlm.nih.gov/pubmed/30517340

Latest in Pulmonary Research

  1. Zhang, GM. Commentary: plasma-derived circALG8 and circCAMTA1 as a panel for early diagnosis of non-small cell lung cancer. Biomark Med. 2025; :1. doi: 10.1080/17520363.2025.2573580. PubMed PMID:41070581 .
  2. Acar, D, Berk, ÖS. The Role of Illness Representations and Metacognitive Beliefs in Mood in People with Type 2 Diabetes: A study from the COVID-19 Period. Turk Psikiyatri Derg. 2025;36 :58. doi: 10.5080/u27707. PubMed PMID:41070516 .
  3. Kiliç, C, Türkoğlu, Ö, Avanoğlu, KB, Grubu, PÇ, Yağcioğlu, EA, Uluğ, BD et al.. Effect of the COVID-19 Pandemic on Psychiatric Service Use Among Psychiatric Outpatients. Turk Psikiyatri Derg. 2025;36 :27. doi: 10.5080/u27455. PubMed PMID:41070490 .
  4. Aşut, G, Ceran, S, Bilgili, GÖ. The Relationship Between Social Media Use, Intolerance of Uncertainty, and Resilience with Anxiety and Depression Symptoms in Cancer Patients. Turk Psikiyatri Derg. 2025;36 :22. doi: 10.5080/u27431. PubMed PMID:41070485 .
  5. Ghandour, M, Gerges, NE, Zeaiter, N. The Prevalence and Determinants of Mental Health Problems in Lebanon: A Meta-Analytic Study of 3957 Healthcare Workers. Turk Psikiyatri Derg. 2025;36 :17. doi: 10.5080/u27427. PubMed PMID:41070480 .
  6. Yilmaz, H. COVID-19 and Mania: A Case with a One-year Follow UP. Turk Psikiyatri Derg. 2025;36 :7. doi: 10.5080/u27284. PubMed PMID:41070466 .
  7. Bolt Botnen, A, Krause Knudsen, L, Grau, J, Bang, H, Nielsen, J, Krog, J et al.. Primary care sentinel surveillance of influenza-like illness and laboratory detections of respiratory viral infections in Denmark, week 40 2021 to week 39 2023. Euro Surveill. 2025;30 (40):. doi: 10.2807/1560-7917.ES.2025.30.40.2500103. PubMed PMID:41070454 .
  8. Sadeghi, H, Khoei, SG. Response to Commentary On: Encoding Genes of Metallo-β-Lactamases (IMP, NDM, and VIM) in Klebsiella pneumoniae in Iran: A Systematic Review and Meta-Analysis. Health Sci Rep. 2025;8 (10):e71357. doi: 10.1002/hsr2.71357. PubMed PMID:41070389 PubMed Central PMC12504623.
  9. Yang, H, Ma, J, Tian, C, Bao, S, Zhang, J, Wang, F et al.. Effective dose to immune cells combined with platelet-to-lymphocyte ratio predicts lymphopenia and prognosis in unresectable locally advanced non-small cell lung cancer. Front Immunol. 2025;16 :1657972. doi: 10.3389/fimmu.2025.1657972. PubMed PMID:41070362 PubMed Central PMC12504879.
  10. Baig, MMA, Baig, MU, Imran, MM. FEF2575 percentage reversibility and its comparison with FEV1 Reversibility in diagnosis of asthma. Pak J Med Sci. 2025;41 (9):2623-2627. doi: 10.12669/pjms.41.9.11535. PubMed PMID:41070321 PubMed Central PMC12505917.
  11. Khor, ZX. Chronic Empyema Necessitans Perpetuated by ESBLKlebsiella pneumoniae. Respirol Case Rep. 2025;13 (10):e70374. doi: 10.1002/rcr2.70374. PubMed PMID:41070276 PubMed Central PMC12505246.
  12. Cane, VI, Gottschalk, M, Vincent, AT, Cane, FD, Sarradell, JE, Cane, JL et al.. Serotype distribution of Actinobacillus pleuropneumoniae isolated from diseased pigs in Argentina (2020-2024). Can J Vet Res. 2025;89 (4):149-152. . PubMed PMID:41070216 PubMed Central PMC12507058.
  13. Ou, Y, Cao, J, Qin, B, Luo, Z, Du, H, Duan, Y et al.. Lung consolidation absorption time in 238 pediatric cases of mycoplasma pneumoniae pneumonia. Front Pediatr. 2025;13 :1606834. doi: 10.3389/fped.2025.1606834. PubMed PMID:41070163 PubMed Central PMC12504092.
  14. Xu, X, Deng, Y, Han, J, Wang, J, Huang, R, Zhao, X et al.. Analysis of risk factors contributing to neonatal pneumonia in low birth weight neonates. Front Pediatr. 2025;13 :1620077. doi: 10.3389/fped.2025.1620077. PubMed PMID:41070159 PubMed Central PMC12504310.
  15. Wang, X, Yang, X, Yao, Y, Hu, H, Zhao, Y, Zhu, Z et al.. Prediction of Antibiotic Efficacy in Cerebral Hemorrhage-Associated Pneumonia Using Inflammatory Hematological Indices: A Retrospective Study. J Inflamm Res. 2025;18 :13763-13772. doi: 10.2147/JIR.S553806. PubMed PMID:41070116 PubMed Central PMC12507047.
  16. Zhu, W, Zhang, L, Zhang, J, Wang, W, Xiang, Y, He, D et al.. Kimura Disease: Retrospective Analysis of 53 Cases and Three Mepolizumab-Responsive Cases. J Inflamm Res. 2025;18 :13773-13785. doi: 10.2147/JIR.S538560. PubMed PMID:41070115 PubMed Central PMC12506796.
  17. Mouliade, C, Parlati, L, Tzedakis, S, Collier, M, Bouam, S, Vallet-Pichard, A et al.. Cystic fibrosis liver disease progression in the era of elexacaftor-tezacaftor-ivacaftor. JHEP Rep. 2025;7 (10):101512. doi: 10.1016/j.jhepr.2025.101512. PubMed PMID:41070102 PubMed Central PMC12506492.
  18. Wang, Q, Liu, L, Zhang, Q, Li, H, Ma, Q. Dynamic performance and scenario-based screening strategy of six COPD questionnaires: a cross-sectional study with prevalence-driven robustness validation. Front Med (Lausanne). 2025;12 :1666703. doi: 10.3389/fmed.2025.1666703. PubMed PMID:41070055 PubMed Central PMC12504273.
  19. Zhang, Y, Chen, A, Yang, C, Guan, L, Wang, C. Metagenomic next-generation sequencing assists in diagnosing Pneumocystis Jirovecii pneumonia in non-HIV patients: a case report. Respir Med Case Rep. 2025;58 :102289. doi: 10.1016/j.rmcr.2025.102289. PubMed PMID:41070051 PubMed Central PMC12506431.
  20. Qin, Z, Li, L, Hou, M, Wang, C. The relationship between prognostic nutritional index and its components (albumin and lymphocyte count) and all-cause mortality in lung cancer patients: a hospital-based study with database external validation. Front Nutr. 2025;12 :1649334. doi: 10.3389/fnut.2025.1649334. PubMed PMID:41070027 PubMed Central PMC12505659.
  21. Malekrah, A, Amiri, S, Alipour, A, Asgary, N. The Crucial Role of Physical Activity Index, in Predicting the Incidence of Pacemaker Syndrome. J Arrhythm. 2025;41 (5):e70189. doi: 10.1002/joa3.70189. PubMed PMID:41070005 PubMed Central PMC12504143.
  22. Jones, C, Laws, M, Yousuf, S, Delo, A, Hartzell, S, Kinder, E et al.. From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma. Front Allergy. 2025;6 :1645968. doi: 10.3389/falgy.2025.1645968. PubMed PMID:41069989 PubMed Central PMC12504475.
  23. Pattanaik, AA, Hashmi, RUA, Dandsena, RS, Sahoo, S, Verma, P, Ghosal, S et al.. Multimorbidity in India: an analysis of prevalence and patterns of chronicity of diseases among older adults using Study on global AGEing and adult health (SAGE) Wave 2. BMJ Public Health. 2025;3 (2):e002143. doi: 10.1136/bmjph-2024-002143. PubMed PMID:41069972 PubMed Central PMC12506212.
  24. Chiablaem, K, Lirdprapamongkol, K, Svasti, J. Pomegranate root extract possesses anti-metastatic potential by suppressing invasiveness and vasculogenic mimicry capability of cancer cells. Biochem Biophys Rep. 2025;44 :102290. doi: 10.1016/j.bbrep.2025.102290. PubMed PMID:41069962 PubMed Central PMC12505693.
  25. Cherrez-Ojeda, I, Frye, BC, Hoheisel, A, Cortes-Telles, A, Robles-Velasco, K, Mateos-Toledo, HN et al.. Evaluation of large language model-generated medical information on idiopathic pulmonary fibrosis. Front Artif Intell. 2025;8 :1618378. doi: 10.3389/frai.2025.1618378. PubMed PMID:41069931 PubMed Central PMC12504196.
Search PubMed

Search Terms: Asthma, COPD, Lung Cancer, Pneumonia, Pulmonary Fibrosis

Back to top